EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
1.630
+0.160 (10.88%)
Apr 23, 2025, 4:00 PM EDT - Market closed
EDAP TMS Revenue
In the year 2024, EDAP TMS had annual revenue of 64.12M EUR with 6.11% growth. EDAP TMS had revenue of 20.32M in the quarter ending December 31, 2024, with 3.59% growth.
Revenue (ttm)
64.12M EUR
Revenue Growth
+6.11%
P/S Ratio
0.92
Revenue / Employee
206,823 EUR
Employees
310
Market Cap
60.95M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 64.12M | 3.69M | 6.11% |
Dec 31, 2023 | 60.42M | 5.31M | 9.64% |
Dec 31, 2022 | 55.11M | 11.04M | 25.06% |
Dec 31, 2021 | 44.07M | 2.40M | 5.77% |
Dec 31, 2020 | 41.66M | -3.25M | -7.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
EDAP News
- 1 day ago - EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting - GlobeNewsWire
- 27 days ago - EDAP TMS S.A. (EDAP) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results - GlobeNewsWire
- 6 weeks ago - EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 - GlobeNewsWire
- 7 weeks ago - EDAP Appoints Glen French to Board of Directors - GlobeNewsWire
- 2 months ago - Cortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center - GlobeNewsWire
- 3 months ago - EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures - GlobeNewsWire
- 3 months ago - EDAP Appoints Joshua H. Levine to Board of Directors - GlobeNewsWire